Complix to Present at BioCapital Europe 2014

Complix to Present at BioCapital EuropeComplix to Present at BioCapital Europe 2014 PR Newswire HASSELT, Belgium, March 26, 2014 Complix, a biopharmaceutical company focused on the discovery and development of Cell Penetrating Alphabodies™ (CPABs), a unique class of protein therapeutics that are active against intracellular disease targets, announces that its CEO Dr Mark